openPR Logo
Press release

Coronary Stents Pipeline Insight Market Research Report 2020 | REVA Medical, Rontis AG, Tepha Inc, Terumo Corp, TissueGen, VasoTech, Biotronik Outlook, Product Types & Application, Industry Dynamics, Pipeline Analysis

09-20-2020 06:35 PM CET | Health & Medicine

Press release from: Mart Research

/ PR Agency: Mart Research
Coronary Stents Pipeline Insight Market Research Report

Coronary Stents Pipeline Insight Market Research Report

Coronary Stents - Pipeline Insight and Competitive Landscape, 2020 report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Coronary Stents pipeline landscape. Owing to the rise in the prevalence of coronary artery diseases (CAD), the coronary stents market is witnessing remarkable growth. Significant players are focusing on expanding their geographical reach, for dominating the current market.

According to the Centre for Disease Control and Prevention, about one-third of the population in the U.S. is obese. The change in lifestyle such as physical inactivity, smoking, drinking, and mistimed and unhealthy food habits are among the major reasons leading to health problems such as obesity, hypertension, arterial blockage, and others. Therefore, owning to all this, there is a significant rise in the pipeline of coronary stents recently.

This reports provides a detailed study of the emerging coronary stents devices along with competitive landscape to help better understand the market.
Geography Covered
- Global coverage

Coronary Stents: Overview
Coronary Stents: Understanding
Coronary stents are small, wire, mesh tubes that help widen a clogged artery and restore adequate blood flow to the heart. During the procedure, the cardiologist place the stent over a thin, long tube with a balloon tip called a catheter and insert it into an artery in groin or arm. Once the stent reaches the clogged artery, the doctor will inflate the balloon to expand the stent. When the stent reaches the desired size to widen the clogged artery, the doctor will deflate and remove the balloon. The stent will stay in place permanently to help prop open the artery and decrease its chance of narrowing again. Over time, the inner lining of the artery will grow over the surface of the stent, making it a permanent part of artery.

Request a Sample of Coronary Stents Pipeline Insight Market Research Report @ https://martresearch.com/contact/request-sample/2/46040

Types of Coronary Stents
Bare-Metal Stents: Tt is tiny wire mesh tubes that help widen a clogged artery, but are not coated with a polymer or drugs to help prevent re-blockage of the artery. This type of stent may be used in patients who are allergic to either the polymer or drugs used in drug-eluting stents.
Drug-Eluting Stents: A drug-eluting stent is a bare-metal stent that has been coated with a polymer that gradually releases a drug over the time when re-blockage is most likely to happen. This helps reduce the chance of the artery becoming blocked again. There are two types of drug-eluting stents: Permanent Polymer Drug-Eluting Stent and Bioabsorbable Polymer Drug-Eluting Stent.

Coronary Stents: Competitive Assessment
This segment of the coronary stents devices pipeline report encloses its detailed analysis of various pipeline devices which include product description, licensing and collaboration details and other developmental activities including the latest news and press releases. The report also provides list of major players involved in the pipeline product development.

- Product Type
The coronary stents is segmented on the basis of product Bare Metal Stents (BMS), Drug Eluting Stents (DES) and Bioresorbable Vascular Scaffolds (BVS).

- Product Biomaterial
Coronary Stents can be divided based upon the biomaterials Metallic (Cobalt Chromium (CoCr), Platinum Chromium (Pt-Cr), Stainless Steel, Nickel Titanium), Polymeric Biomaterial and Natural Biomaterial.

- Major Players in Coronary Stents
There are approx. 20+ key companies which are developing the products for Coronary Stents.

- Cre8 EVO: Alvimedica
Cre8 EVO is a highly innovative Drug Eluting Stent (DES) that is designed to face the clinical outcome challenges when treating patients undergoing percutaneous coronary intervention. That is what Cre8 EVO is; a DES born from the most innovative technology to date. It is manufactured by CID S.p.A. member of Alvimedica group. It has receive CE approval and currently not available in US and japan. The company is also evaluating safety, efficacy and deliverability of the CRE8 sirolimus-eluting stent system in the treatment of patients with de novo coronary artery lesions.

- ArterioSorb: Arterius
ArterioSorb is an innovative medical implant product currently being developed by Arterius, a UK medical device micro/SME, to treat coronary artery disease (CAD). It is a next-generation bioresorbable cardiovascular scaffold (BRS, stent), ArterioSorb, to be implanted within the coronary arteries in order to open blocked vessels, and to biodegrade within two years when healing is complete and it is no longer needed. Arterius will perform the in-vitro and in-vivo studies necessary to demonstrate the safety and efficacy of ArterioSorb. After completion of this study, the company will enter the First-in-Man trials and commercialization process.

Further product details are provided in the report…..

Coronary Stents: Competitive Benchmarking
This segment of the reports provides analysis of the pipeline report to give a clear understanding of the comparative analysis.

The analysis is based on
- Brand Positioning of Leading companies
- Application
- Industry Collaborations

Coronary Stents: Commercialization Activity
This segment of the report provides a detailed list of any commercial activity in the field of coronary stents ranging from collaboration, mergers and acquisition, recent breakthrough among others.
Development Activities

- In the year 2018, Abbott received the approval from the United States Food and Drug Administration (USFDA) for a new generation coronary stent system, named as XIENCE Sierra

- In April 2019, The National Pharmaceutical Pricing Authority (NPPA) of India has approved a hike in the price of coronary stents, with the bare metal stents now priced at ?8,261 (exclusive of GST) as against the existing ?7,660. Drug eluting/biodegradable stents cost ?30,080 (exclusive of GST) as against ?27,890.

Further commercial activities are provided in the report…..

Coronary Stents: Reimbursement
- US

As part of drug-eluting stent programs, medical device companies are proactively identifying strategies to help reduce the lag time between the anticipated introduction of drug-eluting stents and appropriate reimbursement for procedures using them. For example, Boston Scientific is working with hospitals to assess the potential impact of drug-eluting stents on cardiovascular practices as hospitals consider the potential impact of this technology into their service mix. Hospitals and Boston Scientific are evaluating the potential effects of drug-eluting stents within the hospital at multiple levels, including: Procedure Disease Cardiac Catheterization Lab Cardiovascular Unit Hospital Health Care Systems The company has completed a series of analyses that consider the economic drivers relevant to hospitals use of drug-eluting stents, including possible changes in resource use (immediate stenting procedure, reintervention rate, and shifts to and from other services, including coronary artery bypass graft), as well as the costs and clinical outcomes associated with these resources. The purpose of these analyses is to estimate the effect of drug-eluting stents in order to support reimbursement from insurers, as well as to assist providers in resource use and practice management.

Further information is provided in the report…..

Browse the Full Coronary Stents Pipeline Insight Market Research Report @ https://martresearch.com/market-analysis/coronary-stents-pipeline-insight-and-competitive-landscape/2/46040

Report Highlights
- Extensive coverage of the Coronary Stents under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Coronary Stents and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
- The report consists of in depth analysis of pipeline products based on various parameters

Coronary Stents Report Insights
- Coronary Stents - Pipeline Analysis
- Coronary Stents - Unmet Need
- Coronary Stents - Market Dynamics
- Coronary Stents - Future Perspectives and Conclusion
- Coronary Stents - Analyst Views

Key Questions
- What are significant companies in this segment, their information, analysis, and insights to improve R&D strategies?
- How to identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage?
- What are important and diverse types of Coronary Stents under development?
- What are market-entry and market expansion strategies in Coronary Stents?
- What are some of the mergers and acquisitions and to identify major players with the most promising pipeline?
- What is in-depth analysis of the product’s current stage of development, territory and estimated launch date?

Key Players
- REVA Medical Inc
- Rontis AG
- S3V Vascular Technologies
- Sahajanand Medical Technologies Pvt Ltd
- Shanghai Bio-heart Biological Technology Co Ltd
- Stentys SA
- Svelte Medical Systems Inc
- Tepha Inc
- Terumo Corp
- TissueGen Inc
- TrendyMED Inc.
- VasoTech Inc.
- Viller Scientific LLC
- Vornia Biomaterials Ltd
- Xenogenics Corporation
- Biotronik AG
- Cardionovum GmbH
- Concept Medical Inc
- Contego Medical LLC
- Cordis Corp
- DISA Vascular (Pty) Ltd
- Elixir Medical Corp
- Envision Scientific Pvt Ltd
- Aachen Resonance GmbH
- Abbott Vascular Inc
- Adcomp Technologies Inc.
- Aeon Bioscience
- AlviMedica Medical Technologies Inc
- Amaranth Medical Inc
- Arterius Ltd
- Atrium Medical Corp
- Bactiguard Holding AB
- Bionext Biotech Products Ltd.
- Biosten, LLC
- Systems, Inc.
- ID Nest Medical SAS
- InspireMD Inc
- Japan Stent Technology Co., Ltd.
- JW Medical Systems Ltd
- Kaneka Corp
- Kyoto Medical Planning Co Ltd
- Liaoning Biomedical Materials R&D Center Co Ltd
- Lifetech Scientific (Shenzhen) Co Ltd
- MangoGen Pharma Inc
- Manli Cardiology Ltd
- Medinol Ltd
- Medtronic plc
- Miami Cardiovascular Innovations
- Micell Technologies Inc
- MicroPort Scientific Corp
- Minvasys SAS
- MIV Therapeutics Inc
- NanoCoeur, Inc.
- Nanova, Inc
- Nesstent Ltd.
- Nexeon MedSystems Inc
- NuVascular Technologies Inc
- OrbusNeich
- Pediastent LLC
- QualiMed Innovative Medizinprodukte GmbH
- Qvanteq AG
- Relisys Medical Devices Ltd

Buy Full Coronary Stents Pipeline Insight Market Research Report @ https://martresearch.com/paymentform/2/46040/Single_User

Contact Us:
Mart Research
5708 Copper Creek Court Charlotte North Carolina 28227, USA
+1-857-300-1122
sales@martresearch.com

About Us:
We, at MART RESEARCH value your time the most as we believe that time saved is directly proportional to profits earned. Before launching ourselves into this service, we did an extensive survey to understand the challenges clients face while gaining access to authentic data reports. The need of the hour was a common platform which could showcase published reports across a wide range of sectors. To overcome this limitation, we setup a repository which is a comprehensive one-stop shop for all your report requirements. It is user friendly, easy to browse, search and acquire reports which would fulfill your generalized as well as customized business needs.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Coronary Stents Pipeline Insight Market Research Report 2020 | REVA Medical, Rontis AG, Tepha Inc, Terumo Corp, TissueGen, VasoTech, Biotronik Outlook, Product Types & Application, Industry Dynamics, Pipeline Analysis here

News-ID: 2137764 • Views: 690

More Releases from Mart Research

Deep Brain Stimulation Devices Pipeline Insight Market Research Report 2020 | Ad …
Deep Brain Stimulation Devices - Pipeline Insight and Competitive Landscape, 2020 report provides comprehensive insights about 20+ companies and 23+ pipeline devices in deep brain stimulation (DBS) devices pipeline landscape. The DBS market is expected to undergo substantial growth in the coming years owning to an increasing prevalence of neurological disorders around the world. The growing aging population is also a major growth factor for DBS devices market as
Artificial Lung Devices Pipeline Insight Market Research Report 2020 | ALung Tec …
Artificial Lung Devices - Pipeline Insight and Competitive Landscape, 2020 report provides comprehensive insights about 20+ companies and 23+ pipeline devices in artificial lung devices pipeline landscape. Globally, number of cases related to respiratory failure and cardiopulmonary collapse has grown rapidly. This has resulted in increasing demand for artificial lung that acts as an external support system providing oxygenation of blood and removal of carbon dioxide from the blood. Researcher
Biopsy Devices Pipeline Insight Market Research Report 2020 | Outlook, Product T …
Biopsy Devices - Pipeline Insight and Competitive Landscape, 2020 report provides comprehensive insights about 20+ companies and 23+ pipeline devices in biopsy devices pipeline landscape. Significant increase in incidence of cancer, such as breast, prostate, and lung, and rapid technological advancements such as 3D optical biopsies, MRI-targeted biopsies, and Ultrasound-guided biopsies fuel the adoption of biopsy devices. Moreover, rise in awareness on diagnosis of chronic diseases fosters the demand for
Vascular Grafts Pipeline Insight Market Research Report 2020 | RegenaGraft, Huma …
Vascular Grafts - Pipeline Insight and Competitive Landscape, 2020 report provides comprehensive insights about 20+ companies and 25+ pipeline devices in Vascular Grafts pipeline landscape. Heart disease has been the world's biggest cause of mortality, with this trend forecast to continue into the near future. Common disorders contribute to blood vessel stenosis or occlusion. Surgeries using vascular grafts such as coronary artery bypass grafting and peripheral artery bypass grafting is

All 5 Releases


More Releases for Stent

Gel Stent Markets- gel stent market include AqueSysInc. and ALLERGAN.
The Zion Market Research added a new report “Gel Stent Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024” in its database, which provides an expert and in-depth analysis of key business trends and future market development prospects, key drivers and restraints, profiles of major market players, segmentation and forecasting. Gel Stent Market Market research report which provides an in-depth examination of the market scenario regarding market size, share,
Stent Grafts Market : Foraying into Emerging Economies
A stent graft is a tube shaped device composed of a rigid structure called a stent (mostly a metal) and a special fabric covering the stent. A stent is a metal mesh without any covering but a stent graft has a fabric covering and is mainly used in endovascular surgeries. A stent graft is used to repair abdominal aortic aneurysm (AAA) in a procedure called as endovascular aneurysm repair (EVAR).
Coronary Stent Market Influential Share of 2025
Global Coronary Stent Market: Overview The alarming rise in the number of cardiovascular diseases has become the primary growth driver for the global coronary stent market. Changing lifestyles that are characterized by high stress levels, alcohol consumption, smoking, and poor choice of food habits have collectively led to questionable heart health for the global market. The World Health Organization states that the cardiovascular diseases have become the leading cause of deaths
Stent Grafts Global Market For 2017: By Application - Peripheral Stent Grafts, A …
Researchmoz added Most up-to-date research on "Stent Grafts Global Market For 2017: By Application - Peripheral Stent Grafts, Aortic Stent Grafts & Other" to its huge collection of research reports. This report studies Stent Grafts in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global EVAR Stent Grafts Sales Market: By Product Type - Abdominal Aortic Stent …
Researchmoz added Most up-to-date research on "Global EVAR Stent Grafts Sales Market: By Product Type - Abdominal Aortic Stent Grafts & Thoracic Aortic Stent Grafts" to its huge collection of research reports. This report studies sales (consumption) of EVAR Stent Grafts in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions,
Global Bioresorbable Stent Market Research Report 2017
If you want to ask a sample report or make an order, please contact us: Email: lynne@qyresearch.com Web: http://qyresearchglobal.com/ In this report, the global Bioresorbable Stent market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. The Global And China Bioresorbable Stent Industry 2017 Market Research